Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.165NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
V.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.149NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.413NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.107NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDFNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.575.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.620NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDMNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.16 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.10.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.34.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.55NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.64NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.8 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.7 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.90 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-20659South Korea
BF.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.87NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.58 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBGNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.98 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used